Beta Bionics, Inc. (BBNX): Total Liabilities
$41.13M
As of 2025-12-31
$36.02M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $41.13M | -44.1% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $73.63M | +43.2% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $51.43M | n/a | 2025-03-28, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $41.13M | -44.1% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $86.53M | -0.1% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $98.81M | +9.4% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $75.17M | -2.4% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $62.34M | -10.1% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $12.41M | +58.3% |
| Iradimed Corp (IRMD) | 2025-12-31 | $14.16M | +23.0% |
| TELA Bio, Inc. (TELA) | 2025-12-31 | $75.11M | +29.2% |
| PRO DEX Inc (PDEX) | 2026-06-30 | $26.88M | +9.4% |
Compare BBNX, NPCE, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗